Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Radiopharm Theranostics Limited ( (AU:RAD) ) is now available.
Radiopharm Theranostics Limited has requested a trading halt on its securities pending an announcement related to a capital raising effort. The halt is expected to last until the announcement is made or until the market opens on October 20, 2025. This move indicates a significant financial maneuver that could impact the company’s operations and market positioning.
The most recent analyst rating on (AU:RAD) stock is a Buy with a A$0.05 price target. To see the full list of analyst forecasts on Radiopharm Theranostics Limited stock, see the AU:RAD Stock Forecast page.
More about Radiopharm Theranostics Limited
Radiopharm Theranostics Limited operates in the biotechnology industry, focusing on the development and commercialization of radiopharmaceutical products for diagnostic and therapeutic purposes. The company is listed on the Australian Securities Exchange (ASX) under the ticker RAD.
Average Trading Volume: 4,506,841
Technical Sentiment Signal: Buy
Current Market Cap: A$85.14M
See more data about RAD stock on TipRanks’ Stock Analysis page.